Fused Tricyclic Guanidine Alkaloids : Insights into Their Structure, Synthesis and Bioactivity
A marine natural product possesses a diverse and unique scaffold that contributes to a vast array of bioactivities. Tricyclic guanidine alkaloids are a type of scaffold found only in marine natural products. These rare skeletons exhibit a wide range of biological applications, but their synthetic approaches are still limited. Various stereochemical assignments of the compounds remain unresolved. Batzelladine and ptilocaulins are an area of high interest in research on tricyclic guanidine alkaloids. In addition, mirabilins and netamines are among the other tricyclic guanidine alkaloids that contain the ptilocaulin skeleton. Due to the different structural configurations of batzelladine and ptilocaulin, these two main skeletons are afforded attention in many reports. These two main skeletons exhibit different kinds of compounds by varying their ester chain and sidechain. The synthetic approaches to tricyclic guanidine alkaloids, especially the batzelladine and ptilocaulin skeletons, are discussed. Moreover, this review compiles the first and latest research on the synthesis of these compounds and their bioactivities, dating from the 1980s to 2022.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Marine drugs - 20(2022), 9 vom: 17. Sept. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Abd Rani, Nur Zahirah [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 26.09.2022 Date Revised 28.09.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/md20090579 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM346521734 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM346521734 | ||
003 | DE-627 | ||
005 | 20231226031649.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/md20090579 |2 doi | |
028 | 5 | 2 | |a pubmed24n1155.xml |
035 | |a (DE-627)NLM346521734 | ||
035 | |a (NLM)36135769 | ||
035 | |a (PII)579 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Abd Rani, Nur Zahirah |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fused Tricyclic Guanidine Alkaloids |b Insights into Their Structure, Synthesis and Bioactivity |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.09.2022 | ||
500 | |a Date Revised 28.09.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a A marine natural product possesses a diverse and unique scaffold that contributes to a vast array of bioactivities. Tricyclic guanidine alkaloids are a type of scaffold found only in marine natural products. These rare skeletons exhibit a wide range of biological applications, but their synthetic approaches are still limited. Various stereochemical assignments of the compounds remain unresolved. Batzelladine and ptilocaulins are an area of high interest in research on tricyclic guanidine alkaloids. In addition, mirabilins and netamines are among the other tricyclic guanidine alkaloids that contain the ptilocaulin skeleton. Due to the different structural configurations of batzelladine and ptilocaulin, these two main skeletons are afforded attention in many reports. These two main skeletons exhibit different kinds of compounds by varying their ester chain and sidechain. The synthetic approaches to tricyclic guanidine alkaloids, especially the batzelladine and ptilocaulin skeletons, are discussed. Moreover, this review compiles the first and latest research on the synthesis of these compounds and their bioactivities, dating from the 1980s to 2022 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a batzelladines | |
650 | 4 | |a bioactivities | |
650 | 4 | |a guanidine alkaloids | |
650 | 4 | |a marine sponges | |
650 | 4 | |a mirabilins | |
650 | 4 | |a netamines | |
650 | 4 | |a ptilocaulins | |
650 | 4 | |a synthesis | |
650 | 4 | |a tricyclic guanidine | |
650 | 7 | |a Alkaloids |2 NLM | |
650 | 7 | |a Biological Products |2 NLM | |
650 | 7 | |a Esters |2 NLM | |
650 | 7 | |a Guanidines |2 NLM | |
650 | 7 | |a Guanidine |2 NLM | |
650 | 7 | |a JU58VJ6Y3B |2 NLM | |
700 | 1 | |a Lee, Yean Kee |e verfasserin |4 aut | |
700 | 1 | |a Ahmad, Sarfraz |e verfasserin |4 aut | |
700 | 1 | |a Meesala, Ramu |e verfasserin |4 aut | |
700 | 1 | |a Abdullah, Iskandar |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Marine drugs |d 2007 |g 20(2022), 9 vom: 17. Sept. |w (DE-627)NLM179368389 |x 1660-3397 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2022 |g number:9 |g day:17 |g month:09 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/md20090579 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2022 |e 9 |b 17 |c 09 |